Wei Yang

Contact Information

Office 
(631) 216-2802

Email 
wei.yang@stonybrookmedicine.edu

Stony Brook University
Address
Stony Brook, NY 11794-7025

image
Wei Yang Research Lab

Wei Yang, PhD

Associate Professor Department of Pathology
Renaissance School of Medicine at Stony Brook University

Research Program

Oncogenic Drivers and Mechanisms of Carcinogenesis

Department

Department of Pathology

Research Interest

Harnessing the power of multi-level proteomics to understand and prevent cancer metastasis, which is responsible for about 90% of cancer deaths.

Research Summary

RIPK2 in Cancer Metastasis

In our recent publication (Nature Communications, 2022), we showed that the RIPK2 protein kinase is frequently overexpressed in lethal prostate cancer and that targeting RIPK2 reduced prostate cancer metastasis in mice by up to 92%. Using multi-level proteomics, we discovered that RIPK2 functions primarily through a non-canonical RIPK2/MKK7/c-Myc phosphorylation pathway. We are currently investigating the upstream regulators of RIPK2, additional downstream effectors and pathways of RIPK2, and the roles of RIPK2 in metastasis and immune evasion, as well as developing new small-molecule compounds to more specifically targeting the non-canonical RIPK2 signaling pathways. These studies will be expanded to several other cancer types where RIPK2 overexpression is associated with significantly shorter patient survival.

Protein Palmitoylation in Cancer Metastasis

Akin to protein phosphorylation, protein palmitoylation is a reversible post-translational modification that plays a critical role in cancer progression and metastasis. We developed cutting-edge palmitoyl-proteomics methods (Molecular & Cellular Proteomics, 2010Analytical Chemistry, 2019) and applied them to address multiple interesting biological questions (Blood, 2011Journal of Extracellular Vesicles, 2020International Journal of Biological Sciences, 2020Cellular and Molecular Life Sciences, 2021). For a review of palmitoyl-proteomics approaches, refer to our review articles (Journal of Proteomics & Bioinformatics, 2014Journal of Proteome Research, 2021). We are currently investigating the roles and mechanisms of two palmitoylating enzymes, DHHC11 and DHHC2, in prostate cancer metastasis using our leading-edge palmitoyl-proteomics approaches.


Education

2001-2006   PhD- Peking University, Beijing, China 2006-2010   Research Fellow - Harvard Medical School/Boston Childrens' Hospital, Boston, MA

Publications URL

https://www.ncbi.nlm.nih.gov/myncbi/wei.yang.8/bibliography/public/